127
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Peripheral complete blood cell count indices and serum lipid levels in polypoidal choroidal vasculopathy

ORCID Icon, , , , &
Pages 532-537 | Received 15 Oct 2021, Accepted 13 May 2022, Published online: 29 May 2022

References

  • Wong CW, Yanagi Y, Lee WK, et al. Age-Related macular degeneration and polypoidal choroidal vasculopathy in Asians. Prog Retin Eye Res 2016; 53: 107–139.
  • Imamura Y, Engelbert M, Iida T, et al. Polypoidal choroidal vasculopathy: a review. Surv Ophthalmol 2010; 55: 501–515.
  • Laude A, Cackett PD, Vithana EN, et al. Polypoidal choroidal vasculopathy and neovascular age-related macular degeneration: same or different disease?. Prog Retin Eye Res 2010; 29: 19–29.
  • Xu N, Xu H, Zhao M, et al. Associations of systemic, serum lipid and lipoprotein metabolic pathway gene variations with polypoidal choroidal vasculopathy in China. PLoS One 2019; 14: e0226763.
  • Kumar S, Nakashizuka H, Jones A, et al. Proteolytic degradation and inflammation play critical roles in polypoidal choroidal vasculopathy. Am J Pathol 2017; 187: 2841–2857.
  • Cheung CM, Laude A, Yeo I, et al. Systemic, ocular and genetic risk factors for age-related macular degeneration and polypoidal choroidal vasculopathy in Singaporeans. Sci Rep 2017; 7: 41386.
  • Kikuchi M, Nakamura M, Ishikawa K, et al. Elevated C-reactive protein levels in patients with polypoidal choroidal vasculopathy and patients with neovascular age-related macular degeneration. Ophthalmology 2007; 114: 1722–1727.
  • Zhao M, Bai Y, Xie W, et al. Interleukin-1β level is increased in vitreous of patients with neovascular age-related macular degeneration (nAMD) and polypoidal choroidal vasculopathy (PCV). PLoS One 2015; 10: e0125150.
  • Ma L, Li Z, Liu K, et al. Association of genetic variants with polypoidal choroidal vasculopathy: a systematic review and updated meta-analysis. Ophthalmology 2015; 122: 1854–1865.
  • Khalid A, Ali Jaffar M, Khan T, et al. Hematological and biochemical parameters as diagnostic and prognostic markers in SARS-COV-2 infected patients of Pakistan: a retrospective comparative analysis. Hematology 2021; 26: 529–542.
  • Aktas G, Sit M, Dikbas O, et al. Could red cell distribution width be a marker in Hashimoto’s thyroiditis?. Exp Clin Endocrinol Diabetes 2014; 122: 572–574.
  • Atak B, Aktas G, Duman TT, et al. Diabetes control could through platelet-to-lymphocyte ratio in hemograms. Rev Assoc Med Bras (1992) 2019; 65: 38–42.
  • Posul E, Yilmaz B, Aktas G, et al. Does neutrophil-to-lymphocyte ratio predict active ulcerative colitis? Wien Klin Wochenschr 2015; 127: 262–265.
  • Ustaoglu M, Aktas G, Avcioglu U, et al. Elevated platelet distribution width and red cell distribution width are associated with autoimmune liver diseases. Eur J Gastroenterol Hepatol 2021; 33: e905–e908.
  • Kosekli MA. Mean platelet volume and platelet to lymphocyte count ratio are associated with hepatitis B-related liver fibrosis. Eur J Gastroenterol Hepatol 2022; 34: 324–327.
  • Dagistan Y, Dagistan E, Gezici AR, et al. Could red cell distribution width and mean platelet volume be a predictor for lumbar disc hernias?. Ideggyogyaszati szemle 2016; 69: 411–414.
  • Pinna A, Porcu T, Marzano J, et al. Mean platelet volume, red cell distribution width, and complete blood cell count indices in retinal vein occlusions. Ophthalmic Epidemiol 2021; 28: 39–47.
  • Ulu SM, Dogan M, Ahsen A, et al. Neutrophil-To-Lymphocyte ratio as a quick and reliable predictive marker to diagnose the severity of diabetic retinopathy. Diabetes Technol Ther 2013; 15: 942–947.
  • Niazi S, Krogh Nielsen M, Sørensen Tl, et al. Neutrophil-To-Lymphocyte ratio in age-related macular degeneration: a systematic review and meta-analysis. Acta Ophthalmol 2019; 97: 558–566.
  • Wong Wl, Su X, Li X, et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health 2014; 2: e106–116.
  • Zhang X, Li M, Wen F, et al. Different impact of high-density lipoprotein-related genetic variants on polypoidal choroidal vasculopathy and neovascular age-related macular degeneration in a Chinese Han population. Exp Eye Res 2013; 108: 16–22.
  • Kaarniranta K, Pawlowska E, Szczepanska J, et al. Role of mitochondrial DNA damage in ROS-mediated pathogenesis of age-related macular degeneration (AMD). Int J Mol Sci 2019; 20.
  • Heppner FL, Ransohoff RM, Becher B. Immune attack: the role of inflammation in Alzheimer disease. Nat Rev Neurosci 2015; 16: 358–372.
  • Libby P, Kobold S. Inflammation: a common contributor to cancer, aging, and cardiovascular diseases-expanding the concept of cardio-oncology. Cardiovasc Res 2019; 115: 824–829.
  • Tso MOM, Suarez MJ, Eberhart CG. Pathologic study of early manifestations of polypoidal choroidal vasculopathy and pathogenesis of choroidal neo-vascularization. Am J Ophthalmol Case Rep 2018; 11: 176–180.
  • Rea IM, Gibson DS, McGilligan V, et al. Age and age-related diseases: role of inflammation triggers and cytokines. Front Immunol. 2018;9:586.
  • Krogh Nielsen M, Hector SM, Allen K, et al. Altered activation state of circulating neutrophils in patients with neovascular age-related macular degeneration. Immun Ageing 2017; 14: 18.
  • Lechner J, Chen M, Hogg RE, et al. Peripheral blood mononuclear cells from neovascular age-related macular degeneration patients produce higher levels of chemokines CCL2 (MCP-1) and CXCL8 (IL-8). J Neuroinflammation 2017; 14: 42.
  • Ilhan N, Daglioglu MC, Ilhan O, et al. Assessment of neutrophil/lymphocyte ratio in patients with age-related macular degeneration. Ocul Immunol Inflamm 2015; 23: 287–290.
  • Lechner J, Chen M, Hogg RE, et al. Alterations in circulating immune cells in neovascular age-related macular degeneration. Sci Rep 2015; 5: 16754.
  • Pinna A, Porcu T, D’-Amico-Ricci G, et al. Complete blood cell count-derived inflammation biomarkers in men with age-related macular degeneration. Ocul Immunol Inflamm 2019; 27: 932–936.
  • Ferreira JP, Lamiral Z, Bakris G, et al. Red cell distribution width in patients with diabetes and myocardial infarction: an analysis from the EXAMINE trial. Diabetes Obes Metab 2021; 23: 1580–1587.
  • Cansu D, Teke H, Korkmaz C. Etanercept-Induced leukemia: could increased mean corpuscular volume be a predictor of hematologic malignancy? Rheumatol Int 2017; 37: 1381–1385.
  • Green R, Dwyre DM. Evaluation of macrocytic anemias. Semin Hematol 2015; 52: 279–286.
  • Solak Y, Yilmaz MI, Saglam M, et al. Mean corpuscular volume is associated with endothelial dysfunction and predicts composite cardiovascular events in patients with chronic kidney disease. Nephrology (Carlton) 2013; 18: 728–735.
  • Wang H, Yang G, Zhao J, et al. Association between mean corpuscular volume and severity of coronary artery disease in the northern Chinese population: a cross-sectional study. J Int Med Res 2020; 48: 300060519896713.
  • Hsieh YP, Chang CC, Kor CT, et al. Mean corpuscular volume and mortality in patients with CKD. Clin J Am Soc Nephrol 2017; 12: 237–244.
  • Zhu DD, Liu X. Neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in branch retinal vein occlusion. J Ophthalmol 2019; 2019: 6043612.
  • Kurtul BE, Ozer PA. The relationship between neutrophil-to-lymphocyte ratio and age-related macular degeneration. Korean J Ophthalmol 2016; 30: 377–381.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.